Sports Research CLA 1250, Max Strength, 1,250 mg, 90 Softgels
UPC: 023249010562
Sports Research's CLA 1250 is a max-strength softgel supplement designed to support a healthy lifestyle by influencing fatty acid metabolism, as described by the manufacturer. Each softgel provides 1,250 mg of safflower seed oil concentrate, delivering 1,187 mg of conjugated linoleic acid (CLA), a fatty acid that must be obtained through diet, with a high 95% active CLA content derived from non-GMO safflower oil.
This product uses a liquid softgel delivery system, which the manufacturer notes is hermetically sealed and filler-free, based on over 40 years of experience in softgel production. It is third-party tested, gluten-free, and IGEN™ non-GMO verified, with manufacturing in cGMP-compliant facilities. The softgels are also available in a 180-count size.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Calories | 15 | † |
| Total Fat | 1.5 g | 2%** |
| Safflower Seed Oil Concentrate | 1250 mg | † |
| CLA (conjugated linolenic acid) | 1187 mg | † |
| † Daily Value not established | ||
Other Ingredients
Softgel capsule (gelatin, vegetable glycerin, purified water, carob [for color]).
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
Adults take 1 softgel 3 times daily with food, or as recommended by a qualified healthcare professional.
Warning
Keep out of reach of children and pets. Consult with a qualified healthcare professional prior to using this product, especially if you are pregnant, nursing, have a diagnosed medical condition, or are taking a prescription medication. Do not exceed recommended daily intake. Do not use if safety seal is damaged or missing. Store at room temperature, in a dry place. Protect product from excessive heat, freezing, humidity and light.
Product Info
- Brand
- Sports Research
- UPC
- 023249010562
- Package Qty
- 90 count
- Dimensions
- 4.4 x 2.55 x 2.55 in
- Shipping Weight
- 0.45 lb
- First Available
- 04/2017
